3 ms·
The really interesting part of this study (besides the obvious self-experimentation) is that she underwent subtype conversion from TN to HER2+ tumor and thus co
by markus92 2y ago
The really interesting part of this study (besides the obvious self-experimentation) is that she underwent subtype conversion from TN to HER2+ tumor and thus could use Trastuzumab.
- CipherThrowaway 2y agoThe development of PD-L1 expression was also interesting.